Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry

Experimental and Molecular Pathology

Volumn 81, Issue 2, 2006, Pages 176-180

  Liang, Yong ^a,b   Fang, Marong ^a   Li, Jicheng ^a   Liu, Chi Bo ^b   Rudd, John A ^c   Kung, H F ^c   Yew, David T W ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarker; Cancer; Gastric adenocarcinoma; Gastritis; SELDI

Indexed keywords

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; GASTRITIS; HUMAN; MAJOR CLINICAL STUDY; MORPHOLOGY; PROTEIN EXPRESSION; PROTEOMICS; SERUM; STOMACH CANCER; STOMACH LESION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; ADENOCARCINOMA; BLOOD; CANCER INVASION; CASE CONTROL STUDY; COMPARATIVE STUDY; MASS SPECTROMETRY; METHODOLOGY; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR;

TUMOR MARKER;

ADENOCARCINOMA; CASE-CONTROL STUDIES; GASTRITIS; HUMANS; NEOPLASM INVASIVENESS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750943175     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.04.008     Document Type: Article

References (24)

1. Banez L.L., Prasanna P., Sun L., Ali A., Zou Z., Adam B.L., McLeod D.G., Moul J.W., and Srivastava S. Diagnostic potential of serum proteomic patterns in prostate cancer. J. Urol. 170 (2003) 442-446
2. Becker S., Cazares L.H., Watson P., Lynch H., Semmes O.J., Drake R.R., and Laronga C. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann. Surg. Oncol. 11 (2004) 907-914
3. Carpelan-Holmstrom M., Louhimo J., Stenman U.H., Alfthan H., and Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 22 (2002) 2311-2316
4. Conrads T.P., Fusaro V.A., Ross S., Johann D., Rajapakse V., Hitt B.A., Steinberg S.M., Kohn E.C., Fishman D.A., Whitely G., Barrett J.C., Liotta L.A., Petricoin III E.F., and Veenstra T.D. High-resolution serum proteomic features for ovarian cancer detection. Endocr. Relat. Cancer 11 (2004) 163-178
5. Fung E.T., Yip T.T., Lomas L., Wang Z., Yip C., Meng X.Y., Lin S., Zhang F., Zhang Z., Chan D.W., and Weinberger S.R. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int. J. Cancer 115 (2005) 783-789
6. Grotzinger C., Kneifel J., Patschan D., Schnoy N., Anagnostopoulos I., Faiss S., Tauber R., Wiedenmann B., and Gessner R. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 49 (2001) 73-81
7. Hamler R.L., Zhu K., Buchanan N.S., Kreunin P., Kachman M.T., Miller F.R., and Lubman D.M. A two-dimensional liquid-phase separation method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification. Proteomics 4 (2004) 562-577
8. Issaq H.J., Veenstra T.D., Conrads T.P., and Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292 (2002) 587-592
9. Kodera Y., Ito S., Yamamura Y., Mochizuki Y., Fujiwara M., Hibi K., Ito K., Akiyama S., and Nakao A. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann. Surg. Oncol. 10 (2003) 898-902
10. Laronga C., Becker S., Watson P., Gregory B., Cazares L., Lynch H., Perry R.R., Wright Jr. G.L., Drake R.R., and Semmes O.J. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis. Markers 19 (2003-2004) 229-238
11. Leung W.K., and Sung J.J. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment. Pharmacol Ther. 16 (2002) 1209-1216
12. Li J., Zhao J., Yu X., Lange J., Kuerer H., Krishnamurthy S., Schilling E., Khan S.A., Sukumar S., and Chan D.W. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin. Cancer Res. 11 (2005) 8312-8320
13. Makela J.T., Kiviniemi H., Wiik H., and Laitinen S. Survival after surgery for gastric cancer in patients over 70 years of age. Ann. Chir. Gynaecol. 89 (2000) 268-272
14. Ohata H., Oka M., Yanaoka K., Shimizu Y., Mukoubayashi C., Mugitani K., Iwane M., Nakamura H., Tamai H., Arii K., Nakata H., Yoshimura N., Takeshita T., Miki K., Mohara O., and Ichinose M. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci. 96 (2005) 713-720
15. Pan W., Ishii H., Ebihara Y., and Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J. Surg. Oncol. 82 (2003) 104-110
16. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., and Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
17. Petricoin E.E., Paweletz C.P., and Liotta L.A. Clinical applications of proteomics: proteomic pattern diagnostics. J. Mammary Gland Biol. Neoplasia 7 (2002) 433-440
18. Roboz J. Mass spectrometry in diagnostic oncoproteomics. Cancer Invest. 23 (2005) 465-478
19. Schneider J., Bitterlich N., and Schulze G. Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK. Anticancer Res. 25 (2005) 1507-1515
20. Shevchenko A., Jensen O.N., Podtelejnikov A.V., Sagliocco F., Wilm M., Vorm O., Mortensen P., Shevchenko A., Boucherie H., and Mann M. Free in PMC Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14440-14445
21. Simpkins F., Czechowicz J.A., Liotta L., and Kohn E.C. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. Pharmacogenomics 6 (2005) 647-653
22. Solassol J., Marin P., Demettre E., Rouanet P., Bockaert J., Maudelonde T., and Mange A. Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection. Anal. Biochem. 338 (2005) 26-31
23. Weinberger S.R., Boschetti E., Santambien P., and Brenac V. Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 782 (2002) 307-316
24. Yuan H., Guo S., and Feng S. Analysis of patients survived over ten years after resection of gastric cardia carcinoma. Zhonghua Zhong Liu Za Zhi 21 (1999) 145-147